IMRA Imara

Imara to Present at Upcoming Investor Conferences

Imara to Present at Upcoming Investor Conferences

Citi 16th Annual BioPharma Virtual Conference, H.C. Wainwright 23rd Annual Global Investment Conference and Morgan Stanley 19th Annual Global Healthcare Conference

BOSTON, Sept. 03, 2021 (GLOBE NEWSWIRE) -- Imara Inc. (Nasdaq: IMRA), a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat patients suffering from rare inherited genetic disorders of hemoglobin and other serious diseases, today announced that the Company will participate in the following upcoming virtual investor conferences in September:

Rahul Ballal, Ph.D., President and Chief Executive Officer of Imara, and Ken Attie, M.D., Chief Medical Officer of Imara, will participate in a panel discussion titled “Sickle Cell, Beta-Thal, ITP & PKD Measuring Industry Progress in Benign Hematology” at the on Friday, September 10, 2021 at 12:30 p.m. ET.

Dr. Ballal will give a pre-recorded presentation at the which will be made available on September 13, 2021 at 7:00 a.m. ET.

Dr. Ballal and Dr. Attie will participate in a fireside chat at the on September 15, 2021 at 11:00 a.m. ET.

A live webcast of the presentations will be available under "Events and Presentations" in the Investors section of the company's website at .

About Imara

Imara Inc. is a clinical-stage biotechnology company dedicated to developing and commercializing novel therapeutics to treat patients suffering from rare inherited genetic disorders of hemoglobin and other serious diseases. Imara is currently advancing IMR-687, a highly selective, potent small molecule inhibitor of PDE9 that is an oral, once-a-day, potentially disease-modifying treatment for sickle cell disease and beta-thalassemia. IMR-687 is being designed to have a multimodal mechanism of action that acts on red blood cells, white blood cells, adhesion mediators and other cell types. For more information, please visit .

Media Contact:

Marin Bergman

Ten Bridge Communications

818-516-2746

Investor Contact:

Michael Gray

617-835-4061



EN
03/09/2021

Underlying

IMRAImara

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Imara

 PRESS RELEASE
Free
IMRA IMARA

Imara Announces Stockholder Approval of Merger With Enliven

Imara Announces Stockholder Approval of Merger With Enliven -- Combined Company to Trade on Nasdaq Under Ticker “ELVN” ---- Imara Announces 1-for-4 Reverse Stock Split of Common Stock -- BROOKLINE, Mass., Feb. 22, 2023 (GLOBE NEWSWIRE) -- Imara Inc. (Nasdaq: IMRA) today announced the results of the special meeting of its stockholders held on February 22, 2023. At the special meeting, Imara’s stockholders voted in favor of all proposals, including the proposal to approve the issuance of shares of Imara’s common stock to the stockholders of Enliven Therapeutics, Inc. (“Enliven”) pursuant t...

February 22, 2023 1 EN
Jonathan Moreland
  • Jonathan Moreland
Free Trial
SIX Six Flags Enter...
VRNS Varonis Systems... ... (+24)

InsiderInsights Daily Ratings Report: December 12, 2022

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

SIX SIX FLAGS ENTERTAINMENT CORPORATION
VRNS VARONIS SYSTEMS INC.
PLAY DAVE & BUSTER'S ENTERTAINMENT INC.
MIXT MIX TELEMATICS ADR
HOO HERBALIFE NUTRITION LTD.
CRK COMSTOCK RESOURCES INC.
RLMD RELMADA THERAPEUTICS
NR NEWPARK RESOURCES INC.
SCOR COMSCORE INC.
SPOK SPOK HOLDINGS
ISSC INNOVATIVE SOLUTIONS & SUPPORT INC.
CLAR CLARUS CORPORATION
BRT BRT APARTMENTS
AMEH APOLLO MEDICAL HOLDINGS INC
NKLA NIKOLA CORPORATION
GOCO GOHEALTH
ONEW INC.
IMRA ONEWATER MARINE
MCG IMARA
CADL MEMBERSHIP COLLECTIVE GROUP INC.
BLND CANDEL THERAPEUTICS INC
AIKI ETRACS DJ-UBS COMMODITY INDEX 2-4-6 BLEND
UAMY AIKIDO PHARMA INC.
U S ANTIMONY CORP
12/13/22 December 13, 2022 1 EN
Jonathan Moreland
  • Jonathan Moreland
Free Trial
WOR Worthington Ind...
VCYT VERACYTE INC ... (+53)

InsiderInsights Weekly Report: October 29, 2022

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

WOR WORTHINGTON INDUSTRIES INC.
VCYT VERACYTE INC
TCBI TEXAS CAPITAL BANCSHARES INC.
STRM STREAMLINE HEALTH SOLUTIONS
SBSI SOUTHSIDE BANCSHARES INC.
PLAY DAVE & BUSTER'S ENTERTAINMENT INC.
OPK OPKO HEALTH INC.
MGNX MACROGENICS INC.
HBAN HUNTINGTON BANCSHARES INCORPORATED
FITB FIFTH THIRD BANCORP
FFIN FIRST FINANCIAL BANKSHARES INC
FAST FASTENAL COMPANY
FARM FARMER BROS. CO.
AZZ AZZ INC.
ANGO ANGIODYNAMICS INC.
AHH ARMADA HOFFLER PROPERTIES INC.
EVA ENVIVA PARTNERS LP
BSET BASSETT FURNITURE INDUSTRIES INC.
CCI CROWN CASTLE INTERNATIONAL CORP
THO THOR INDUSTRIES INC.
IGR CBRE CLARION GLOBAL REAL ESTAT
INBK FIRST INTERNET BANCORP
FONR FONAR CORP.
PLSE PULSE BIOSCIENCES
NTIC NORTHERN TECHNOLOGIES INTERNATIONAL
FBK FB FINANCIAL CORPORATION
CDXC CHROMADEX CORP
SNAP SNAP INC. CLASS A
QNST QUINSTREET
RCKT ROCKET PHARMACEUTICALS
INSP INSPIRE MEDICAL SYSTEMS
GIM TEMPLETON GLOBAL INCOME FUND
BOTJ BANK OF THE JAMES FINANCIAL GROUP INC.
SRRK SCHOLAR ROCK HOLDING CORPORATION
FUND ROYCE FOCUS TRUST
PHAS INC.
NGM PHASEBIO PHARMACEUTICALS INC
OTLK NGM BIOPHARMACEUTICALS
DX OUTLOOK THERAPEUTICS
AXLA DYNEX CAPITAL INC.
CABA AXCELLA HEALTH
NREF CABALETTA BIO
BDTX NEXPOINT REAL ESTATE FINANCE
NKLA INC.
IMRA BLACK DIAMOND THERAPEUTICS
BYRN INC.
EPIX NIKOLA CORPORATION
TNGX IMARA
APLD BYRNA TECHNOLOGIES INC
LEXX EPIX PHARMACEUTICALS
TANGO THERAPEUTICS INC
APPLIED BLOCKCHAIN INC
LEXARIA BIOSCIENCE CORP
10/29/22 October 29, 2022 1 EN
Jonathan Moreland
  • Jonathan Moreland
Free Trial
FITB Fifth Third Ban...
CCI Crown Castle In... ... (+6)

InsiderInsights Daily Ratings Report: October 24, 2022

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

FITB FIFTH THIRD BANCORP
CCI CROWN CASTLE INTERNATIONAL CORP
FBK FB FINANCIAL CORPORATION
JYNT THE JOINT
VOXX AUDIOVOX CORPORATION
IMRA IMARA
10/25/22 October 25, 2022 1 EN
Jonathan Moreland
  • Jonathan Moreland
Free Trial
VCYT VERACYTE INC
RMAX RE/MAX Holdings... ... (+36)

InsiderInsights Weekly Report: October 22, 2022

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

VCYT VERACYTE INC
RMAX RE/MAX HOLDINGS INC.
PLAY DAVE & BUSTER'S ENTERTAINMENT INC.
OPK OPKO HEALTH INC.
MGNX MACROGENICS INC.
FAST FASTENAL COMPANY
CAMP CALAMP CORP.
AZZ AZZ INC.
APPF APPFOLIO INC CLASS A
EVA ENVIVA PARTNERS LP
JELD JELD-WEN HOLDING INC.
QNST QUINSTREET
GIM TEMPLETON GLOBAL INCOME FUND
FUND ROYCE FOCUS TRUST
NGM INC.
CCO NGM BIOPHARMACEUTICALS
AXLA CLEAR CHANNEL OUTDOOR HOLDINGS INC
ETNB AXCELLA HEALTH
CABA 89BIO
VOXX CABALETTA BIO
NKLA AUDIOVOX CORPORATION
IMRA NIKOLA CORPORATION
PUBM IMARA
ACR PUBMATIC
GEG ACRES COMMERCIAL REALTY CORP
COIN GREAT ELM GROUP INC
COOK COINBASE GLOBAL
WISH INC.
RKT TRAEGER
MDRR INC.
HSON CONTEXTLOGIC INC.
EMO ROCKET SHARING COMPANY SPA
LEXX MEDALIST DIVERSIFIED REIT INC
HUDSON GLOBAL INC
CLEARBRIDGE ENERGY MLP OPPORTUNITY FUND INC.
LEXARIA BIOSCIENCE CORP
10/24/22 October 24, 2022 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch